Something extraordinary happened to me last weekend. Following three horrid nights of sleep, I spent 13 hours a day for the next three days in a room with 135 people – and emerged in much better condition than when I had started. That I would not have predicted....
It must have seemed like a done deal. Daiichi Sankyo was so confident that its safer, more effective version of Lyrica (pregabalin) called Mirogabalin was going to beat the pants off the best-selling drug for FM. How confident were they? They funded easily the largest...
It was a project birthed in hope. Pal Schaathun, a Norwegian filmmaker would document what he hoped might be the end of chronic fatigue syndrome (ME/CFS). That, unfortunately, turned out not to be but Schaathun ended up documenting – in strikingly beautiful...
I was a bit anxious as I waited for Dr. Pridgen to pick up. It had been a year and a half since we talked and I had heard nothing. Given Pridgen’s approach – using antivirals in a disease (fibromyalgia) that few connected with pathogens – his...
Last March, I trudged out to the van to install a solar panel. I’d been fighting a cold but this was something thing I dearly wanted to get done. In general, I felt a little activity had been helpful with colds. This time, it was different. The work took longer...
In 2015, Dean Echenberg, MD, PhD, a former public health official and Director of Disease Control in San Francisco at the height of the HIV/AIDS epidemic, had a question. His own course of ME/CFS had been anything but smooth. Echenberg had experienced years of illness...
